Fulcrum Therapeutics Inc (FULC)

Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	32.11%29.31	22.19	22.69	21.86	19.82
Research and Development	11.64%12.44	14.08	15.42	14.30	12.99
Operating Income/Loss	32.11%-29.31	-22.19	-22.69	-21.86	-19.82
	38.58%-26.18	-18.89	-20.33	-19.60	-17.30
Attributable To Parent	38.58%-26.18	-18.89	-20.33	-19.60	-17.30
Basic Average Shares	0.06%76.26	76.22	-	62.60	62.54
Diluted Average Shares	0.06%76.26	76.22	-	62.60	62.54
Basic Earnings Per Share	36.00%-0.34	-0.25	-	-0.31	-0.28
Diluted Earnings Per Share	36.00%-0.34	-0.25	-	-0.31	-0.28